• Home
• Browse articles
• Browse issues
• About
  • About this journal
  • FAQ
  • Article processing charge FAQ
  • Contact us
• Editorial board
• Instructions for authors
• For reviewers
• My details

About Alzheimer's Research & Therapy

What is Alzheimer's Research & Therapy?

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer’s disease. An international peer-reviewed journal, it will publish open access research articles of outstanding quality. Alzheimer's Research & Therapy will publish basic research with a translational focus, as well as clinical trials, and research into drug discovery and development. Although the primary focus is Alzheimer’s dementia, the scope will encompass translational research into other neurodegenerative diseases.

Review articles and expert commentary will accompany key papers.

Content overview

Alzheimer's Research & Therapy contains the following types of articles:

• Research articles: reports of data from exceptional original research. These articles will form the major content of the journal.
• Reviews: provide a factual account of recent developments within an area of research. Most are commissioned, though suggestions of topics are always welcome. In-depth reviews provide substantial coverage of a subject in a single longer article, and multi-author thematic series explore a subject in a series of concise, narrowly focused review articles coordinated by a leading authority in the field.
• Commentaries: short, focused and opinionated articles of contemporary interest on any subject within the journal's scope. Most are commissioned, although unsolicited commentaries are welcome and are routinely peer reviewed.
• Viewpoints: short opinion pieces focusing on the latest high-impact research.
• Letters: may discuss material published in Alzheimer's Research & Therapy or particular issues of general interest to the readership.

Peer review policies

All articles will be subject to immediate screening by the Editorial Board. Articles that do not meet the scientific standards of the journal may be declined without further review. Appropriate articles will be sent to up to 4 referees. We make every effort to reach decisions within 6 weeks of submission. If the referees have requested revisions, in general, only one revised version will be considered for further peer-review.

Authors are asked to provide names and contact details for 3 referees. However, final selection of referees is the responsibility of the Editorial Board.

All peer review is closed - authors are not given the names of the referees of their article.

Editorial Board members and referees are asked to declare any competing interests they may have in reviewing a manuscript.

On occasion, authors of rejected articles will be offered the opportunity to submit their research article to one of the other journals published by BioMed Central. Where relevant, the referee reports will be passed on to the second journal, which may expedite the peer review process. Referee reports are not passed on to any journal outside of BioMed Central.

If an author is not satisfied with the decision made on their manuscript, they are welcome to contact the Editorial Office with their appeal. A second opinion on the manuscript will be sought where appropriate.

Edited by Douglas Galasko, Todd Golde and Gordon Wilcock, Alzheimer's Research & Therapy is supported by an expert Editorial Board.

Publishing in Alzheimer's Research & Therapy

All articles will be listed in PubMed immediately upon acceptance (after peer review), and will be covered by PubMed Central.

Articles in Alzheimer's Research & Therapy should be cited in the same way as articles in a traditional journal. However, because articles in this journal are not printed, they do not have page numbers. Instead, they have a unique article number.

The following citation:

Alzheimers Res Ther 2005, 6:R306

refers to research article 306 from volume 6 of the journal.

To keep up to date with the latest articles from Alzheimer's Research & Therapy, why not register to receive alerts? Registration also enables you to customise your subject areas of interest, store your searches, and submit your manuscripts.

Submission of manuscripts

Manuscripts should be submitted electronically to Alzheimer's Research & Therapy using the online submission system. Full details of how to submit a manuscript are given in the instructions for authors.

General journal policies

Alzheimer's Research & Therapy is published by BioMed Central, an independent publisher committed to ensuring peer-reviewed biomedical research is Open Access. That means it is freely and universally accessible online, it is archived in at least one internationally recognised free access repository, and its authors retain copyright, allowing anyone to reproduce or disseminate articles, according to the BioMed Central copyright and licence agreement.

Alzheimer's Research & Therapy's articles are archived in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and also at INIST in France and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. The journal is also participating in the British Library's e-journals pilot project, and plans to deposit copies of all articles with the British Library.

• Submit a manuscript
• Sign up for article alerts